The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 | Intensive Care Medicine | 2017 | 3.2K |
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | BMJ, The | 2010 | 3.1K |
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria | Lancet Neurology, The | 2018 | 2.4K |
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial | Lancet, The | 2016 | 2.3K |
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 | Critical Care Medicine | 2017 | 1.7K |
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors | Clinics in Colon and Rectal Surgery | 2009 | 1.3K |
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials | Journal of Clinical Epidemiology | 2010 | 1.2K |
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study | Lancet Oncology, The | 2015 | 1.2K |
Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | Physical Therapy | 2009 | 1.2K |
Scoping reviews: time for clarity in definition, methods, and reporting | Journal of Clinical Epidemiology | 2014 | 1.2K |
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis | New England Journal of Medicine | 2003 | 1K |
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | International Journal of Surgery | 2012 | 1K |
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer | Annals of Internal Medicine | 2001 | 851 |
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia | Nature | 2011 | 846 |
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | PLoS ONE | 2012 | 741 |
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial | Lancet Oncology, The | 2016 | 691 |
Validation of a decision regret scale | Medical Decision Making | 2003 | 687 |
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | BMJ, The | 2021 | 666 |
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers | Cmaj | 2004 | 614 |
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes | Neurology | 2006 | 601 |
Decision aids for patients facing health treatment or screening decisions: systematic review | BMJ: British Medical Journal | 1999 | 577 |
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study | JAMA Oncology | 2017 | 572 |
Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community | Cmaj | 2010 | 557 |
Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis | American Journal of Respiratory and Critical Care Medicine | 2010 | 515 |